NCT01827631 Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01827163 Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer Status COMPLETED Phase PHASE2
NCT01823159 Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study Status COMPLETED Phase PHASE3
NCT01822899 A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01822665 Gastrointestinal Safety Evaluation of Two Over the Counter Analgesics Status COMPLETED Phase PHASE4
NCT01822639 A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study Status COMPLETED Phase PHASE1
NCT01821625 Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C Status TERMINATED Phase PHASE2/PHASE3
NCT01818024 A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01818011 A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects Status TERMINATED Phase PHASE1
NCT01817790 Assessment of Fluticasone Propionate on Ocular Allergy Symptoms Status COMPLETED Phase PHASE3
NCT01817777 An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes Status TERMINATED Phase PHASE4
NCT01817764 A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01813136 Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma Status COMPLETED Phase PHASE2
NCT01808482 A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Status TERMINATED Phase PHASE1
NCT01808339 To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma Status COMPLETED Phase PHASE2
NCT01808326 A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT01808313 Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE3